Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 22 11:41AM ET
0.8536
Dollar change
+0.0220
Percentage change
2.65
%
Index- P/E- EPS (ttm)-0.81 Insider Own33.99% Shs Outstand14.78M Perf Week2.84%
Market Cap12.62M Forward P/E- EPS next Y-0.32 Insider Trans-4.52% Shs Float9.76M Perf Month-32.25%
Income-11.98M PEG- EPS next Q-0.10 Inst Own0.84% Short Float0.59% Perf Quarter-0.75%
Sales0.00M P/S- EPS this Y39.06% Inst Trans- Short Ratio0.08 Perf Half Y-74.13%
Book/sh0.30 P/B2.88 EPS next Y17.95% ROA- Short Interest0.06M Perf Year-
Cash/sh0.31 P/C2.74 EPS next 5Y- ROE- 52W Range0.76 - 7.98 Perf YTD-18.70%
Dividend Est.- P/FCF- EPS past 5Y- ROI-273.92% 52W High-89.30% Beta-
Dividend TTM- Quick Ratio8.70 Sales past 5Y0.00% Gross Margin- 52W Low12.32% ATR (14)0.10
Dividend Ex-Date- Current Ratio8.70 EPS Y/Y TTM- Oper. Margin0.00% RSI (14)37.24 Volatility12.17% 8.76%
Employees3 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom- Target Price-
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q-219.59% Payout- Rel Volume0.03 Prev Close0.83
Sales Surprise- EPS Surprise- Sales Q/Q- Earnings- Avg Volume691.29K Price0.85
SMA20-14.64% SMA50-20.62% SMA200-67.63% Trades Volume7,062 Change2.65%
Apr-02-24 08:00AM
Apr-01-24 02:53PM
Mar-21-24 11:04AM
Mar-08-24 08:19AM
Feb-05-24 08:30AM
08:00AM Loading…
Dec-04-23 08:00AM
Nov-29-23 08:00AM
Nov-21-23 10:42AM
10:09AM
Nov-20-23 08:00AM
Oct-26-23 07:23AM
Sep-18-23 08:30AM
Sep-05-23 08:31AM
Aug-31-23 08:31AM
Aug-29-23 11:39AM
09:35AM Loading…
Aug-09-23 09:35AM
Aug-03-23 02:40PM
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company engages in developing its product candidate, MIRA1a, as a synthetic cannabinoid analog for treating anxiety & chronic pain by targeting the cannabinoid type 1 and type 2 (CB1 and CB2) receptors. MIRA Pharmaceuticals was founded by Adam Kaplin on September 3, 2020 and is headquartered in Miami, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McNulty Brian Patrick10% OwnerDec 11 '23Sale1.5546,00571,496660,000Dec 27 05:33 PM
McNulty Brian Patrick10% OwnerDec 08 '23Sale1.6119,05330,633683,002Dec 27 05:33 PM
McNulty Brian Patrick10% OwnerDec 07 '23Sale1.8933,33363,156692,529Dec 27 05:33 PM
McNulty Brian Patrick10% OwnerDec 06 '23Sale2.9527,73381,785709,196Dec 27 05:33 PM
McNulty Brian Patrick10% OwnerDec 04 '23Sale3.9861,331244,097723,062Dec 27 05:33 PM
McNulty Brian Patrick10% OwnerNov 30 '23Sale3.774,84218,273753,728Dec 27 05:33 PM
McNulty Brian Patrick10% OwnerNov 29 '23Sale3.987,39929,445756,149Dec 27 05:33 PM
McNulty Brian Patrick10% OwnerNov 28 '23Sale4.00241964759,849Dec 27 05:33 PM
McNulty Brian Patrick10% OwnerNov 27 '23Sale4.006,42525,715759,969Dec 27 05:33 PM
McNulty Brian Patrick10% OwnerNov 21 '23Sale5.005,00025,000763,181Dec 27 05:33 PM
McNulty Brian Patrick10% OwnerNov 20 '23Sale5.0726,733135,523765,681Dec 27 05:33 PM
Cappy George10% OwnerAug 07 '23Buy7.00119,048833,3362,859,318Aug 24 05:38 PM
Cappy George10% OwnerAug 02 '23Buy7.00157,1701,100,1902,740,270Aug 04 01:42 PM